Janus Henderson Group’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306M | Sell |
10,777,317
-649,379
| -6% | -$18.4M | 0.15% | 147 |
|
|
2025
Q1 | $361M | Buy |
11,426,696
+4,373,686
| +62% | +$138M | 0.2% | 123 |
|
|
2024
Q4 | $205M | Buy |
7,053,010
+2,156,844
| +44% | +$62.7M | 0.1% | 190 |
|
|
2024
Q3 | $225M | Buy |
4,896,166
+1,239,323
| +34% | +$56.9M | 0.12% | 176 |
|
|
2024
Q2 | $149M | Buy |
3,656,843
+2,414,010
| +194% | +$98.7M | 0.08% | 210 |
|
|
2024
Q1 | $31.7M | Buy |
1,242,833
+1,216,730
| +4,661% | +$31M | 0.02% | 477 |
|
|
2023
Q4 | $236K | Sell |
26,103
-38
| -0.1% | -$344 | ﹤0.01% | 2367 |
|
|
2023
Q3 | $167K | Buy |
26,141
+21
| +0.1% | +$134 | ﹤0.01% | 2424 |
|
|
2023
Q2 | $289K | Sell |
26,120
-36
| -0.1% | -$399 | ﹤0.01% | 2266 |
|
|
2023
Q1 | $401K | Buy |
+26,156
| New | +$401K | ﹤0.01% | 2141 |
|
|
2020
Q4 | – | Sell |
-180,446
| Closed | -$5.08M | – | 1419 |
|
|
2020
Q3 | $5.08M | Sell |
180,446
-143,157
| -44% | -$4.03M | ﹤0.01% | 921 |
|
|
2020
Q2 | $9.15M | Buy |
+323,603
| New | +$9.15M | 0.01% | 827 |
|